NCT03514888View on ClinicalTrials.gov

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

July 19, 2021

Study Completion Date

May 23, 2023

Conditions
Invasive Bladder Cancer
Interventions
PROCEDURE

HIPEC

40mg of Mitomycin-C dissolved in 100ml normal saline will be added into the perfusate and instilled into the patient for a total of 60 minutes. After 60 minutes, the abdomen will be irrigated with 3 liters of normal saline.

Trial Locations (1)

10065

Weill Cornell Medicine - New York Presbyterian Hospital, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT03514888 - HIPEC After Radical Cystectomy for High Risk Bladder Cancer | Biotech Hunter | Biotech Hunter